Hammel D, Block M, Geiger A, Böcker D, Stadlbauer T, Breithardt G, Scheld H H
Department of Cardiovascular Surgery, Hospital of the Westphalian Wilhelms University of Muenster, Germany.
Ann Thorac Surg. 1994 Dec;58(6):1614-6. doi: 10.1016/0003-4975(94)91644-6.
This study describes the placement of a newly designed implantable cardioverter defibrillator in a subpectoral device pocket using the incision for venous access in 16 patients undergoing implantation of an implantable cardioverter defibrillator with a nonthoracotomy lead system. The endocardial lead system consisted of a right atrial/superior vena cava defibrillation spring electrode and a right ventricular bipolar sensing/defibrillation electrode, inserted by cephalic venotomy or by puncturing of the subclavian vein. As a result of intraoperative testing using biphasic shocks the defibrillation threshold (DFT) had to be less than 24 J, otherwise an additional subcutaneous patch electrode was placed in the lateral chest wall near the cardiac apex through another incision. All patients received a nonthoracotomy lead system in combination with a subpectoral device placement. In 11 of 16 patients the endocardial leads alone were sufficient (DFT, 13.4 +/- 7.0 J), 5 of 16 patients (31%) required an additional subcutaneous patch electrode to achieve proper device function (DFT, 14.6 +/- 9.0 J). The operation lasted 93 +/- 20 minutes. This was a significant (p < 0.05) lower time consumption than standard nonthoracotomy approach combined with abdominal device placement (120 +/- 50 minutes). There were no postoperative complications. During follow-up period (average, 4 months), none of the patients reported major local symptoms, especially no device migration occurred. This approach, in contrast to an abdominal device placement, avoids another incision and subcutaneous tunneling of leads. In 11 of 16 patients defibrillator implantation by a single incision in the deltoideopectoral groove was possible.
本研究描述了在16例接受非开胸式植入式心律转复除颤器(ICD)植入的患者中,如何利用静脉穿刺切口,将新设计的植入式心律转复除颤器置于胸大肌下的设备袋中。心内膜导线系统由右心房/上腔静脉除颤弹簧电极和右心室双极感知/除颤电极组成,通过头静脉切开术或锁骨下静脉穿刺插入。术中使用双相电击进行测试,结果显示除颤阈值(DFT)必须小于24J,否则需通过另一切口在心脏尖部附近的侧胸壁放置一个额外的皮下贴片电极。所有患者均接受非开胸式导线系统并结合胸大肌下设备植入。16例患者中有11例单独的心内膜导线就足够了(DFT为13.4±7.0J),16例患者中有5例(31%)需要额外的皮下贴片电极才能实现设备的正常功能(DFT为14.6±9.0J)。手术持续时间为93±20分钟。与标准的非开胸方法结合腹部设备植入(120±50分钟)相比,这一时间消耗显著更低(p<0.05)。术后无并发症。在随访期(平均4个月)内,所有患者均未报告严重的局部症状,尤其是未发生设备移位。与腹部设备植入相比,这种方法避免了另一切口和导线的皮下隧道操作。16例患者中有11例可以通过三角肌胸大肌沟处的单一切口进行除颤器植入。